These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 6458872)
1. Qualitative changes in saliva composition after short-term administration of imipramine and zimelidine in healthy volunteers. von Knorring L; Mörnstad H Scand J Dent Res; 1981 Aug; 89(4):313-20. PubMed ID: 6458872 [TBL] [Abstract][Full Text] [Related]
2. Changes in saliva secretion and accommodation width during short-term administration of imipramine and zimelidine in healthy volunteers. von Knorring L Int Pharmacopsychiatry; 1981; 16(2):69-78. PubMed ID: 6460717 [TBL] [Abstract][Full Text] [Related]
3. Long-term effects of two principally different antidepressant drugs on saliva secretion and composition. Mörnstad H; von Knorring L; Forsgren L; Holmgren S Scand J Dent Res; 1986 Oct; 94(5):461-70. PubMed ID: 2948270 [TBL] [Abstract][Full Text] [Related]
4. Saliva secretion rate and saliva composition as a model to determine the effect of antidepressant drugs on cholinergic and noradrenergic transmission. von Knorring L; Mörnstad H Neuropsychobiology; 1986; 15(3-4):146-54. PubMed ID: 2431344 [TBL] [Abstract][Full Text] [Related]
5. Cardiovascular effects of zimelidine and other antidepressant in conscious rats. Lindbom LO; Forsberg T Acta Psychiatr Scand Suppl; 1981; 290():380-4. PubMed ID: 6452801 [TBL] [Abstract][Full Text] [Related]
6. Effect of zimelidine, a new antidepressant, on appetite and body weight. Simpson RJ; Lawton DJ; Watt MH; Tiplady B Br J Clin Pharmacol; 1981 Jan; 11(1):96-8. PubMed ID: 6452151 [No Abstract] [Full Text] [Related]
7. Cardiovascular and anticholinergic effects of zimelidine. Lindbom LO; Malatray J; Hall H; Ogren SO Prog Neuropsychopharmacol Biol Psychiatry; 1982; 6(4-6):403-6. PubMed ID: 6219432 [TBL] [Abstract][Full Text] [Related]
8. Comparative pharmacokinetics of zimelidine and desipramine in man following acute and chronic administration. Potter WZ; Calil HM; Extein I; Zavadil AP; Goodwin FK Psychiatry Res; 1979 Dec; 1(3):273-81. PubMed ID: 298355 [TBL] [Abstract][Full Text] [Related]
9. [Vigilance behavior in interaction of the serotonin-selective antidepressant zimelidine and parenterally administered ethanol]. Schaffler K; Arnold H; Hörmann E Arzneimittelforschung; 1982; 32(8):845-52. PubMed ID: 6215927 [TBL] [Abstract][Full Text] [Related]
10. Zimelidine: a placebo-controlled trial in depression. Norman TR; Burrows GD; Marriott PF; McIntyre IM; Davies BM; Moore RG Psychiatry Res; 1983 Feb; 8(2):95-103. PubMed ID: 6222387 [TBL] [Abstract][Full Text] [Related]
11. Effects of amitriptyline and zimelidine in combination with ethanol. Scott DB; Fagan D; Tiplady B Psychopharmacology (Berl); 1982; 76(3):209-11. PubMed ID: 6212962 [TBL] [Abstract][Full Text] [Related]
12. Controlled trial of zimelidine, a 5-HT reuptake inhibitor, for treatment of depression. Georgotas A; Krakowski M; Gershon S Am J Psychiatry; 1982 Aug; 139(8):1057-8. PubMed ID: 6211994 [TBL] [Abstract][Full Text] [Related]
13. Effects of acute doses of zimelidine on REM sleep in rats. Reyes RB; Hill SY; Kupfer DJ Psychopharmacology (Berl); 1983; 80(3):214-6. PubMed ID: 6225137 [TBL] [Abstract][Full Text] [Related]
14. Changes in endorphins and 5-hydroxyindoleacetic acid in cerebrospinal fluid as a result of treatment with a serotonin reuptake inhibitor (zimelidine) in chronic pain patients. Johansson F; von Knorring L; Sedvall G; Terenius L Psychiatry Res; 1980 May; 2(2):167-72. PubMed ID: 6158065 [TBL] [Abstract][Full Text] [Related]
15. Double-blind comparisons of a selective serotonin reuptake inhibitor, zimelidine, and placebo on quantified EEG parameters and psychological variables. Schenk GK; Filler W; Ranft W; Zerbin D Acta Psychiatr Scand Suppl; 1981; 290():303-13. PubMed ID: 6452797 [TBL] [Abstract][Full Text] [Related]
16. Profile of antidepressant action of zimelidine and norzimelidine compared with amitriptyline. Montgomery SA; Montgomery DB; McAuley R; Rani SJ; Roy D Adv Biochem Psychopharmacol; 1982; 32():35-42. PubMed ID: 6211942 [No Abstract] [Full Text] [Related]
17. Safety data on zimelidine hydrochloride following an overdose. Georgotas A; Mann J; Bush D; Gershon S Acta Psychiatr Scand Suppl; 1981; 290():257-61. PubMed ID: 6452795 [TBL] [Abstract][Full Text] [Related]
18. Reduction of voluntary morphine consumption following treatment with zimelidine. Rockman GE; Amit Z; Bourque C; Brown ZW; Ogren SO Arch Int Pharmacodyn Ther; 1980 Mar; 244(1):123-9. PubMed ID: 6448029 [TBL] [Abstract][Full Text] [Related]
19. Effects of zimelidine on serotoninergic and noradrenergic neurons after repeated administration in the rat. Ross SB; Hall H; Renyi AL; Westerlund D Psychopharmacology (Berl); 1981; 72(3):219-25. PubMed ID: 6164072 [No Abstract] [Full Text] [Related]
20. Long-term treatment with zimelidine leads to a reduction in 5-hydroxytryptamine neurotransmission within the central nervous system of the mouse and rat. Fuxe K; Ogren SO; Agnati LF; Eneroth P; Holm AC; Andersson K Neurosci Lett; 1981 Jan; 21(1):57-62. PubMed ID: 6259561 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]